3.8 Article

Identification of Possible Causative Agents in a Polymedicated Patient Presenting With Toxic Epidermal Necrolysis

Related references

Note: Only part of the references are listed.
Article Medicine, Research & Experimental

Randomized, controlled trial of TNF-alpha antagonist in CTL-mediated severe cutaneous adverse reactions

Chuang-Wei Wang et al.

JOURNAL OF CLINICAL INVESTIGATION (2018)

Review Allergy

Current Perspectives on Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis

Marianne Lerch et al.

CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2018)

Review Allergy

Toxic epidermal necrolysis: Pathophysiology and therapeutic advances

A. -P. Villani et al.

REVUE FRANCAISE D ALLERGOLOGIE (2017)

Article Medicine, General & Internal

A fatal case of cutaneous adverse drug-induced toxic epidermal necrolysis associated with severe rhabdomyolysis

Sheik Oaleed Noordally et al.

ANNALS OF SAUDI MEDICINE (2012)

Editorial Material Pharmacology & Pharmacy

Severe adverse skin reactions to nonsteroidal antiinflammatory drugs: A review of the literature

Kristina E. Ward et al.

AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2010)

Letter Dermatology

Toxic epidermal necrolysis secondary to timolol, dorzolamide, and latanoprost eyedrops

A Flórez et al.

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2005)

Article Dermatology

A case of toxic epidermal necrolysis with lesions mostly on sun-exposed skin

AT Mansur et al.

PHOTODERMATOLOGY PHOTOIMMUNOLOGY & PHOTOMEDICINE (2005)

Article Dermatology

SCORTEN: A severity-of-illness score for toxic epidermal necrolysis

S Bastuji-Garin et al.

JOURNAL OF INVESTIGATIVE DERMATOLOGY (2000)